Back to Video List

Pay-to-view events

This is a video for registered delegates only, please login to watch.

Watch Now

To access more videos and events like this, become a member today!

Join Us


BIR Annual Radiotherapy and Oncology Meeting 2025 Full 06 Mar 2025

Pay-to-view rates:

BIR plan 1 members £315

BIR plan 2 members and trainees £275

BIR retired and student members £175

Non members £500

* VAT added at check out where applicable


The fifth BIR Annual Radiotherapy and Oncology Meeting brought together national and international experts in Radiotherapy and Oncology. This face-to-face meeting had plenty of opportunities for networking with fellow professionals and discussing the latest offerings from industry. 


This is a recording of the full event.


Topics include:

  • Adaptive Radiotherapy
  • Patient Experience
  • Advanced Practice and Workforce
  • Manufacturers
  • New Modalities
  • Retreatment
  • Re-Irradiation
  • Improving Workflows
  • Safety and Regulatory
  • International Collaborations

Who should watch? 

You! If you’re working in radiotherapy and oncology, then this video is designed for you – and that is for all disciplines. The BIR is rapidly becoming the home of ALL professionals involved with Radiotherapy and Oncology and is open to all. So, clinical oncologists, radiographers, physicists, service managers, Linac and IT engineers, dosimetrists, manufacturers, department heads… all are welcome, and there should be something for everyone.


Five Reasons to attend:

  • Enhance your knowledge in the cutting-edge fields of clinical practice
  • Refresh your understanding in key areas
  • Hear expert opinion and offer your own
  • Network with colleagues and peers, manufacturers and industry reps
  • Share your own research and development work

Day One Speakers:

  • Alex Dunlop, Advanced Clinical Research Physicist, The Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden
  • Rachel Hollingdale. Principal Radiotherapy Physicist, Royal Surrey Foundation Trust and Miriam Rashid, Radiotherapy Adaptive Lead, Royal Surrey County Hospital
  • Callum Gillies, Proton Therapy Physicist
  • Joseph Dallman, Research and Technical Development Radiographer, University College Hospital
  • Diane Whitney
  • Dr Anna Barnes
  • Dr Kevin Chiu, Consultant Head and Neck Oncologist, Clinical Lead for Radiation Services, Mount Vernon Cancer Centre
  • Professor Jason Parsons, Chair of Radiobiology, Department of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham
  • Mrs Lamyaa Aljaafari, Postgraduate researcher, University of Leeds
  • Karen Liesching-Schroder
  • Tracey Ellis, Consultant Therapeutic Radiographer and Oncology Clinical Director, Lancashire Teaching Hospital NHS Foundation Trust and Peter Merry
  • Professor Heidi Probst, Professor of Radiotherapy and Oncology, Sheffield Hallam University
  • Emma Hallam, Macmillan Consultant Therapeutic Radiographer, Nottingham University Hospitals NHS Trust
  • Naman Julka-Anderson, Macmillan, Royal Marsden, RadChat
  • Stewart O’Callaghan, OUTPatients
  • Francesco Porcu, Business Line Manager Radiation Oncology, Siemens Healthineers
  • Alexander Malesevic, Medical Physicist and Clinical Sales Manager, C-RAD
  • Ben Huard, Business Manager, Elekta
  • James Carroll, THOR Photomedicine

Day Two Speakers:

  • Professor Marco Durante, Department Director, GSI Helmholtz for Heavy Ion Research
  • Sallie Melsom, Technical Lead Radiographer (Radixact), University Hospital Birmingham
  • Dr Stephen McMahon, Reader, Queen’s University Belfast
  • Dr Emmanuel Stutz, Lead Hyperthemia Unit and Consultant, Department of Radiation Oncology, University Hospital, Inselspital Bern, Switzerland
  • Tuomas Koivumaki, Chief Physicist, Central Hospital Central Finland
  • Miss Elizabeth Harron, Principal Physicist, Clinical Trials, Radiobiology, Training, Nottingham University Hospitals NHS Trust
  • Professor Peter Hoskin, Consultant Clinical Oncologist and Professor of Clinical Oncology, Mount Vernon Cancer Centre and University of Manchester
  • Dr Richard Speight, Principal Clinical Scientist, Leeds Cancer Centre
  • Mr Michael Roche, Principal Physicist (Radiotherapy), Cork University Hospital (HSE)
  • Dr Jonathan Wyatt, Northern Centre for Cancer Care, Newcastle
  • Dr Karen Christaki
  • Professor Pat Price, Consultant Clinical Oncologist, Chair of the Board and Co-Founder, and Chair, Imperial College London, Global Coalition for Radiotherapy, Radiotherapy UK
  • Dr Katie Wakeham, Consultant Clinical Oncologist, Imperial College Healthcare NHS Trust and Global Coalition for Radiotherapy
  • Julia Handley
  • Richard Cowan
  • Aileen Flavin
  • Patty Díez, Lead Clinical Scientist, National Radiotherapy Trials Quality Assurance (RTTQA) Group, Mount Vernon Cancer Centre

12 CPD points

Watch the video and complete the online self-reflection form. Go to "My events" to download your certificate. You must login to watch the video and receive CPD.

Duration: